Please enable JavaScript in your web browser settings, under the site permissions section to unlock full site functionality. Click here for help.

Article Image - OPKO Health Acquires EirGen Pharma

Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Scroll to keep reading

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy

You Might Also Like

Shining The Light On A Medical Marvel

18/12/2019Shining The Light On A Medical Marvel

The fight against cancer has become one of the greatest in modern medical history, and scientific research continues to yield new medical methods for combating this disease. At the forefront of developing innovative technologies is Advanced Oncotherapy, a UK-b

Euro Suffers Further Losses against the US Dollar

05/03/2015Euro Suffers Further Losses against the US Dollar

Mix of slightly weaker Eurozone numbers and decent US number widens gap between currencies.

Agentic AI’s Success Depends on Data Integrity

10/06/2025Agentic AI’s Success Depends on Data Integrity

Interest in autonomous AI tools is accelerating, as businesses look to streamline operations and enhance customer experiences.

6 Benefits of Outsourcing Managed IT Services

02/03/20226 Benefits of Outsourcing Managed IT Services

Outsourcing may be one of the strategies to be considered by businesses to remain focused on the services and products they provide while keeping expenses down.

Empowering Women in Finance and Demystifying the Landscape As Saxo Sees 57% Surge in Female Clients Following Lower Pricing Strategy

07/03/2024Empowering Women in Finance and Demystifying the Landscape As Saxo Sees 57% Surge in Female Clients Following Lower Pricing Strategy

As the financial sphere continues to be rocked by the effects of lockdowns, subsequent supply chain disruptions, an energy crisis and the long-forgotten notion of inflation, Camilla Dahl Hansen, Chief Experience Officer at Saxo Bank, argues now is the time to

Moving Class Outside: Adjusting Academics

13/08/2021Moving Class Outside: Adjusting Academics

When you think of the typical classroom, you’re probably picturing brick walls, rows of desks, a chalkboard and a few decorations that match the subject being taught. Over this past year, though, the traditional classroom has been flipped. The pandemic sent

Pensions Used as an Investment Vehicle for Good

17/08/2021Pensions Used as an Investment Vehicle for Good

Saving for retirement is a distant prospect that only becomes real the closer we get to it, wishing we had started to save seriously earlier. However, could this be about to change for many?

Understanding the Benefits and Importance of Installment Loans

11/01/2022Understanding the Benefits and Importance of Installment Loans

Installment loans could be a real game-changer, especially if you need flexible repayments. In these difficult economic moments, you find that you will need some cash at some point. And that's why you need to know about installment loans.

A Step-by-Step Guide to Starting Your Dropshipping Business

31/01/2022A Step-by-Step Guide to Starting Your Dropshipping Business

It’s no secret that dropshipping is one of the fastest-growing industries in eCommerce. It is a convenient, low-risk business model that you can easily start with just a little capital. You don’t have to worry about managing the stock of goods, and you sim

View More Articles

Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

MORE BRANDS